Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Expose Cancer Cells' Universal 'Dark Matter'

June 27, 2011 12:10 pm | News | Comments

Using the latest gene sequencing tools to examine so-called epigenetic influences on the DNA makeup of colon cancer, a Johns Hopkins team says its results suggest cancer treatment might eventually be more tolerable and successful if therapies could focus on helping cancer cells get back to normal in addition to strategies for killing them.


Titration Assessment Tool

June 27, 2011 6:58 am | Product Releases | Comments

Mettler Toledo introduces the Good Titration Practice Risk Checker, an on-line tool that allows labs to quickly assess their titration risk and the reliability of their results.


Disposable Cuvette

June 27, 2011 6:53 am | Product Releases | Comments

Avid Nano's BladeCell disposable cuvette improves Dynamic Light Scattering sample preparation time by a factor of eight compared to using traditional quartz cuvettes.


Wyatt Instruments Meet EP Standards

June 27, 2011 6:43 am | News | Comments

Wyatt Technology Corporation announces that its multi-angle light scattering instruments represent the latest European Pharmacopoeia requirements for hydroxyethyl starch characterization.


R & D Spending, Approvals Down in 2011

June 27, 2011 6:38 am | News | Comments

The pharmaceutical industry spent less on drug R&D last year than at any time in the last three years, according to data released from the 2011 Pharmaceutical R&D Factbook complied by CMR International.


EnVivo Begins Trial for Potential Alzheimer’s Treatment

June 27, 2011 6:31 am | News | Comments

EnVivo Pharmaceuticals announced that it recently initiated a Phase 1 clinical trial of EVP-0962, its potent and selective gamma secretase modulator, in healthy volunteers.


IST Drug Receives Orphan Drug Status

June 27, 2011 6:25 am | News | Comments

Australian monoclonal antibody company, Immune System Therapeutics Limited, announced that its antibody treatment for terminal blood cancer had received Orphan Drug Designation from US health regulators.


FDA: Lower Doses of Anemia Drugs

June 27, 2011 6:16 am | by Matthew Perrone | News | Comments

U.S. Food and Drug Administration officials say doctors should use lower doses of anemia drugs when treating patients with failing kidneys due to the increased risk of stroke, blood clots and death.


Pfizer Probing Icagen Deal

June 27, 2011 6:11 am | News | Comments

Drugmaker Pfizer Inc. said in a regulatory finding it is studying the possibility of entering a "strategic transaction" with the biopharmaceutical company Icagen Inc. that could result Icagen being acquired.


Dapagliflozin Beats Glipizide in Long-Term Study

June 27, 2011 6:08 am | News | Comments

Bristol-Myers Squibb Co. and AstraZeneca PLC said that dapagliflozin, a potential new drug for Type 2 diabetes patients, holds promise after a late-stage clinical study.


Multimode Microplate Reader

June 24, 2011 12:26 pm | Product Releases | Comments

Tecan has updated its Infinite M1000, a multimode microplate reader with new features.


Microplates for Imaging Applications

June 24, 2011 12:24 pm | Product Releases | Comments

Krystal Glass Bottom Plates from Porvair Sciences provide performance for whole-plate CCD imaging and laser detection applications.


Microplate Sealing Reference Guide

June 24, 2011 12:20 pm | Product Releases | Comments

Agilent Automation Solutions’ “Reference Guide to Optimal Microplate Sealing” was written for laboratories looking to optimize microplate sealing processes to safeguard the integrity of their samples.


A Step Closer to Understanding ‘Natural Antifreeze’ Molecules

June 24, 2011 12:14 pm | News | Comments

Researchers from the Universities of Leeds and Illinois, and Columbia University, studied a particular type of cryoprotectants known as osmolytes. They found that small osmolyte molecules are better at protecting proteins than larger ones.


European Regulators Give Green Light to Shire Manufacturing Site

June 24, 2011 12:09 pm | News | Comments

Irish drugmaker Shire Plc said on June 24 the European Medicines Agency has approved a new manufacturing site in Massachusetts that will be used to make the Fabry disease treatment, Replagal.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.